메뉴 건너뛰기




Volumn , Issue , 2012, Pages 779-789

Less commonly used antiepileptic drugs

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84973429097     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (2)

References (143)
  • 1
    • 84973424799 scopus 로고    scopus 로고
    • February
    • Scott Levin's PPDA, MAT. February 1999.
    • (1999)
  • 2
    • 84944662266 scopus 로고
    • A new series of anticonvulsant drugs tested by experiments on animals
    • Merritt HH, Putnam TJ. A new series of anticonvulsant drugs tested by experiments on animals. Arch Neurol Psychiatry. 1938;39:1003-1015.
    • (1938) Arch Neurol Psychiatry. , vol.39 , pp. 1003-1015
    • Merritt, H.H.1    Putnam, T.J.2
  • 3
    • 37049223719 scopus 로고
    • Experimental determination of anticonvulsant properties of some phenyl derivatives
    • Putnam TJ, Merritt HH. Experimental determination of anticonvulsant properties of some phenyl derivatives. Science. 1937;85:525-526.
    • (1937) Science. , vol.85 , pp. 525-526
    • Putnam, T.J.1    Merritt, H.H.2
  • 4
    • 84942475840 scopus 로고
    • Sodium diphenylhydantoinate in treatment of convulsive disorders
    • Merritt HH, Putnam TJ. Sodium diphenylhydantoinate in treatment of convulsive disorders. J Am Med Assoc. 1938;111:1068-1073.
    • (1938) J Am Med Assoc. , vol.111 , pp. 1068-1073
    • Merritt, H.H.1    Putnam, T.J.2
  • 5
    • 84891512934 scopus 로고
    • Other hydantoins: mephenytoin and ethotoin
    • Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
    • Kupferberg HJ. Other hydantoins: mephenytoin and ethotoin. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:257-266.
    • (1989) Antiepileptic Drugs. , pp. 257-266
    • Kupferberg, H.J.1
  • 7
    • 0021250891 scopus 로고
    • Ethotoin in seizures of childhood and adolescence
    • Carter CA, Helms RA, Boehm R. Ethotoin in seizures of childhood and adolescence. Neurology. 1984;34:791-795.
    • (1984) Neurology. , vol.34 , pp. 791-795
    • Carter, C.A.1    Helms, R.A.2    Boehm, R.3
  • 8
    • 0025325288 scopus 로고
    • Adjunctive therapy for intractable epilepsy with ethotoin
    • Biton V, Gates JR, Ritter FJ, et al. Adjunctive therapy for intractable epilepsy with ethotoin. Epilepsia. 1990;31:433-437.
    • (1990) Epilepsia. , vol.31 , pp. 433-437
    • Biton, V.1    Gates, J.R.2    Ritter, F.J.3
  • 9
    • 0020961246 scopus 로고
    • Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible?
    • Finnell RH, Dilibert JH. Hydantoin-induced teratogenesis: are arene oxide intermediates really responsible? Helv Paediatr Acta. 1983;38: 171-177.
    • (1983) Helv Paediatr Acta. , vol.38 , pp. 171-177
    • Finnell, R.H.1    Dilibert, J.H.2
  • 10
    • 0017605311 scopus 로고
    • Cleft lip and palate with the anticonvulsant ethotoin
    • Zablen M, Brand N. Cleft lip and palate with the anticonvulsant ethotoin. N Engl J Med. 1977;297:1404.
    • (1977) N Engl J Med. , vol.297 , pp. 1404
    • Zablen, M.1    Brand, N.2
  • 12
    • 84939114392 scopus 로고
    • Other succinimides: methsuximide and phensuximide
    • Woodbury DM, Penry JK, Schmidt RP, eds.New York: Raven Press
    • Glazko AJ, Dill WA. Other succinimides: methsuximide and phensuximide. In: Woodbury DM, Penry JK, Schmidt RP, eds. Antiepileptic Drugs. New York: Raven Press; 1972:455-464.
    • (1972) Antiepileptic Drugs. , pp. 455-464
    • Glazko, A.J.1    Dill, W.A.2
  • 13
    • 0018693180 scopus 로고
    • Plasma concentrations of phensuximide, methsuximide and their metabolites in relation to clinical efficacy
    • Porter RJ, Penry JK, Lacy IR, et al. Plasma concentrations of phensuximide, methsuximide and their metabolites in relation to clinical efficacy. Neurology. 1979;29:1509-1513.
    • (1979) Neurology. , vol.29 , pp. 1509-1513
    • Porter, R.J.1    Penry, J.K.2    Lacy, I.R.3
  • 14
    • 0016139051 scopus 로고
    • Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy
    • Strong JM, Abe R, Gibbs EL, et al. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy. Neurology. 1974;24:250-255.
    • (1974) Neurology. , vol.24 , pp. 250-255
    • Strong, J.M.1    Abe, R.2    Gibbs, E.L.3
  • 15
    • 0019401620 scopus 로고
    • Methsuximide for refractory complex partial seizures
    • Wilder BJ, Buchanan RB. Methsuximide for refractory complex partial seizures. Neurology. 1981;31:741-744.
    • (1981) Neurology. , vol.31 , pp. 741-744
    • Wilder, B.J.1    Buchanan, R.B.2
  • 16
    • 0020674597 scopus 로고
    • Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions
    • Browne TR, Feldman RG, Buchanan RA, et al. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 1983;33:414-418.
    • (1983) Neurology. , vol.33 , pp. 414-418
    • Browne, T.R.1    Feldman, R.G.2    Buchanan, R.A.3
  • 17
    • 0343495513 scopus 로고
    • N-methyl-2-methylphenyl-succinimide, in psychomotor epilepsy
    • Coroba EF, Strobos RRJ. N-methyl-2-methylphenyl-succinimide, in psychomotor epilepsy. Dis Nerv Syst. 1956;17:383-385.
    • (1956) Dis Nerv Syst. , vol.17 , pp. 383-385
    • Coroba, E.F.1    Strobos, R.R.J.2
  • 19
    • 0343931315 scopus 로고
    • Methsuximide in psychomotor and petit mal seizures
    • French EG, Rey-Bellet J, Lennox WG. Methsuximide in psychomotor and petit mal seizures. N Engl J Med. 1958;253:892-894.
    • (1958) N Engl J Med. , vol.253 , pp. 892-894
    • French, E.G.1    Rey-Bellet, J.2    Lennox, W.G.3
  • 20
    • 0343495512 scopus 로고
    • Celontin in the treatment of epilepsy
    • Livingston S, Pauli L. Celontin in the treatment of epilepsy. Pediatrics. 1957;19:614-618.
    • (1957) Pediatrics. , vol.19 , pp. 614-618
    • Livingston, S.1    Pauli, L.2
  • 21
    • 0343495507 scopus 로고
    • Use of N-methyl-a,-a-methylphenylsuccinimide in the treatment of petit mal epilepsy
    • Zimmerman FT, Burgemeister BB. Use of N-methyl-a,-a-methylphenylsuccinimide in the treatment of petit mal epilepsy. Arch Neurol Psychiatry. 1954;72:720-725.
    • (1954) Arch Neurol Psychiatry. , vol.72 , pp. 720-725
    • Zimmerman, F.T.1    Burgemeister, B.B.2
  • 22
    • 84973424646 scopus 로고
    • Methsuximide
    • Kutt H, Resor SR, eds.New York: Marcel Dekker:
    • Uthman BM, Wilder BJ. Methsuximide. In: Kutt H, Resor SR, eds. Medical Treatment of Epilepsy. New York: Marcel Dekker; 1991: 379-384.
    • (1991) Medical Treatment of Epilepsy. , pp. 379-384
    • Uthman, B.M.1    Wilder, B.J.2
  • 23
    • 0035010804 scopus 로고    scopus 로고
    • Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood
    • Sigler M, Strassburg HM, Boenigk HE. Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood. Seizure. 2001;10: 120-124.
    • (2001) Seizure. , vol.10 , pp. 120-124
    • Sigler, M.1    Strassburg, H.M.2    Boenigk, H.E.3
  • 24
  • 25
    • 0342625340 scopus 로고
    • Use of Celontin in the treatment of mixed epilepsy
    • Carter CH, Maley MC. Use of Celontin in the treatment of mixed epilepsy. Neurology. 1957;7:483-484.
    • (1957) Neurology. , vol.7 , pp. 483-484
    • Carter, C.H.1    Maley, M.C.2
  • 26
    • 0343931314 scopus 로고
    • Celontin in patients with refractory epilepsy
    • Dow RW, McFarlane JP, Stevens JR. Celontin in patients with refractory epilepsy. Neurology. 1958;8:201-204.
    • (1958) Neurology. , vol.8 , pp. 201-204
    • Dow, R.W.1    McFarlane, J.P.2    Stevens, J.R.3
  • 28
    • 0342625339 scopus 로고
    • N-methyl-a,a-methylphenylsuccinimide in psychomotor epilepsy treatment
    • Zimmerman FT. N-methyl-a,a-methylphenylsuccinimide in psychomotor epilepsy treatment. Arch Neurol Psychiatry. 1956;76:65-71.
    • (1956) Arch Neurol Psychiatry. , vol.76 , pp. 65-71
    • Zimmerman, F.T.1
  • 29
    • 0004960971 scopus 로고
    • Minor motor epilepsy: diagnosis, treatment and prognosis
    • Livingston S, Eisner V, Pauli L. Minor motor epilepsy: diagnosis, treatment and prognosis. Pediatrics. 1958;21:916-928.
    • (1958) Pediatrics. , vol.21 , pp. 916-928
    • Livingston, S.1    Eisner, V.2    Pauli, L.3
  • 30
    • 0342625322 scopus 로고
    • Celontin (Petinutin)-a contribution to the differential therapy of epilepsy [German]
    • Rabe F. Celontin (Petinutin)-a contribution to the differential therapy of epilepsy [German]. Nervenarzt. 1960;7:306-312.
    • (1960) Nervenarzt. , vol.7 , pp. 306-312
    • Rabe, F.1
  • 32
    • 0029867296 scopus 로고    scopus 로고
    • Methsuximide therapy of juvenile myoclonic epilepsy
    • Hurst DL. Methsuximide therapy of juvenile myoclonic epilepsy. Seizure. 1996;5:47-50.
    • (1996) Seizure. , vol.5 , pp. 47-50
    • Hurst, D.L.1
  • 33
    • 0018397002 scopus 로고
    • Pharmacological interactions of methsuximide with phenobarbital and phenytoin in hospitalized epileptic patients
    • Rambeck B. Pharmacological interactions of methsuximide with phenobarbital and phenytoin in hospitalized epileptic patients. Epilepsia. 1979;20:147-156.
    • (1979) Epilepsia. , vol.20 , pp. 147-156
    • Rambeck, B.1
  • 34
    • 0018616686 scopus 로고
    • Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy
    • Eichelbaum M, Kothe KW, Hoffmann F, et al. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy. Clin Pharmacol Ther. 1979;26:366-371.
    • (1979) Clin Pharmacol Ther. , vol.26 , pp. 366-371
    • Eichelbaum, M.1    Kothe, K.W.2    Hoffmann, F.3
  • 35
    • 0032946127 scopus 로고    scopus 로고
    • Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study
    • May T, Rambeck B, Jurgens U. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study. Ther Drug Monit. 1999;21:175-181.
    • (1999) Ther Drug Monit. , vol.21 , pp. 175-181
    • May, T.1    Rambeck, B.2    Jurgens, U.3
  • 36
    • 0035184525 scopus 로고    scopus 로고
    • Methsuximide reduces valproic acid serum levels
    • Besag FM, Berry DJ, Vasey M. Methsuximide reduces valproic acid serum levels. Ther Drug Monit. 2001;23:694-697.
    • (2001) Ther Drug Monit. , vol.23 , pp. 694-697
    • Besag, F.M.1    Berry, D.J.2    Vasey, M.3
  • 37
    • 0036786119 scopus 로고    scopus 로고
    • Does lamotrigine influence valproate concentrations?
    • Mataringa MI, May TW, Rambeck B. Does lamotrigine influence valproate concentrations? Ther Drug Monit. 2002;24:631-636.
    • (2002) Ther Drug Monit. , vol.24 , pp. 631-636
    • Mataringa, M.I.1    May, T.W.2    Rambeck, B.3
  • 38
    • 0034098269 scopus 로고    scopus 로고
    • Methsuximide lower lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction
    • Besag FM. Methsuximide lower lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction. Epilepsia. 2000;41:624-627.
    • (2000) Epilepsia. , vol.41 , pp. 624-627
    • Besag, F.M.1
  • 39
    • 0036001230 scopus 로고    scopus 로고
    • Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication
    • May TW, Rambeck B, Jurgens U. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication. Ther Drug Monit. 2002;24:366-374.
    • (2002) Ther Drug Monit. , vol.24 , pp. 366-374
    • May, T.W.1    Rambeck, B.2    Jurgens, U.3
  • 40
    • 0025723419 scopus 로고
    • Methsuximide-induced movement disorder
    • Dooley J, Camfield P, Buckley D, et al. Methsuximide-induced movement disorder. Pediatrics. 1991;88:1291-1292.
    • (1991) Pediatrics. , vol.88 , pp. 1291-1292
    • Dooley, J.1    Camfield, P.2    Buckley, D.3
  • 41
    • 0015837008 scopus 로고
    • Methsuximide overdose: delayed onset of profound coma
    • Karch SB. Methsuximide overdose: delayed onset of profound coma. J Am Med Assoc. 1973;223:1463-1465.
    • (1973) J Am Med Assoc. , vol.223 , pp. 1463-1465
    • Karch, S.B.1
  • 42
    • 0018940159 scopus 로고
    • Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose
    • Baehler RW, Work J, Smith W, et al. Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose. Arch Intern Med. 1980;140:1466-1468.
    • (1980) Arch Intern Med. , vol.140 , pp. 1466-1468
    • Baehler, R.W.1    Work, J.2    Smith, W.3
  • 43
    • 0001072003 scopus 로고
    • Luminal bei Epilepsie
    • Hauptman A. Luminal bei Epilepsie. Munch Med Wochenschr. 1912;59: 1907-1909.
    • (1912) Munch Med Wochenschr. , vol.59 , pp. 1907-1909
    • Hauptman, A.1
  • 44
    • 0021887675 scopus 로고
    • Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures
    • Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med. 1985;313:145-151.
    • (1985) N Engl J Med. , vol.313 , pp. 145-151
    • Mattson, R.H.1    Cramer, J.A.2    Collins, J.F.3
  • 45
    • 0025012995 scopus 로고
    • Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence
    • Farwell JR, Lee YJ, Hirtz DG, et al. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364-369.
    • (1990) N Engl J Med. , vol.322 , pp. 364-369
    • Farwell, J.R.1    Lee, Y.J.2    Hirtz, D.G.3
  • 46
    • 0023028242 scopus 로고
    • Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial
    • Goldberg RN, Moscoso P, Bauer CR, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr. 1986;109:851-856.
    • (1986) J Pediatr. , vol.109 , pp. 851-856
    • Goldberg, R.N.1    Moscoso, P.2    Bauer, C.R.3
  • 48
    • 0041755459 scopus 로고
    • How to use phenobarbital
    • Morselli PL, Pippenger CE, Penry JK, eds.New York: Raven Press
    • Painter MJ. How to use phenobarbital. In: Morselli PL, Pippenger CE, Penry JK, eds. Antiepileptic Drug Therapy in Pediatrics. New York: Raven Press; 1983:245-250.
    • (1983) Antiepileptic Drug Therapy in Pediatrics. , pp. 245-250
    • Painter, M.J.1
  • 49
    • 0021274545 scopus 로고
    • Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants: a controlled study of bilirubin disappearance and infant behavior
    • Wallin A, Boreus LO. Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants: a controlled study of bilirubin disappearance and infant behavior. Acta Pediatr Scand. 1984;73:488-497.
    • (1984) Acta Pediatr Scand. , vol.73 , pp. 488-497
    • Wallin, A.1    Boreus, L.O.2
  • 50
    • 84912847588 scopus 로고
    • Phenobarbital mechanisms of action
    • Woodbury D, Penry JK, Pippenger CE, eds.2nd ed. New York: Raven Press
    • Pritchard JW. Phenobarbital mechanisms of action. In: Woodbury D, Penry JK, Pippenger CE, eds. Antiepileptic Drugs. 2nd ed. New York: Raven Press; 1982:1332-1335.
    • (1982) Antiepileptic Drugs. , pp. 1332-1335
    • Pritchard, J.W.1
  • 51
    • 0019402780 scopus 로고
    • Qualitative and quantitative studies of methylphenobarbital metabolism in man
    • Hooper WD, Kunze HE, Eadie MJ. Qualitative and quantitative studies of methylphenobarbital metabolism in man. Drug Metab. 1981;9:381-385.
    • (1981) Drug Metab. , vol.9 , pp. 381-385
    • Hooper, W.D.1    Kunze, H.E.2    Eadie, M.J.3
  • 52
    • 0014991269 scopus 로고
    • Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats
    • Craig CR, Shideman FE. Metabolism and anticonvulsant properties of mephobarbital and phenobarbital in rats. J Pharmacol Exp Ther. 1971; 176:35-41.
    • (1971) J Pharmacol Exp Ther. , vol.176 , pp. 35-41
    • Craig, C.R.1    Shideman, F.E.2
  • 53
    • 0014912667 scopus 로고
    • Stereospecificity of anaesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates
    • Buch H, Knabe J, Buzello W, et al. Stereospecificity of anaesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. J Pharmacol Exp Ther. 1970;176:709-716.
    • (1970) J Pharmacol Exp Ther. , vol.176 , pp. 709-716
    • Buch, H.1    Knabe, J.2    Buzello, W.3
  • 54
    • 50549218994 scopus 로고
    • Demethylation of N-methyl derivatives of barbituric acid, hydantoin and 2,4-oxazolidinedione by rat liver microsomes
    • Smith JA, Waddell WJ, Butler TC. Demethylation of N-methyl derivatives of barbituric acid, hydantoin and 2,4-oxazolidinedione by rat liver microsomes. Life Sci. 1963;7:486-492.
    • (1963) Life Sci. , vol.7 , pp. 486-492
    • Smith, J.A.1    Waddell, W.J.2    Butler, T.C.3
  • 55
    • 0006462822 scopus 로고
    • The role of the liver in the metabolic disposition of mephobarbital
    • Butler TC, Mahaffee D, Mahaffee C. The role of the liver in the metabolic disposition of mephobarbital. J Pharmacol Exp Ther. 1952;106:364-369.
    • (1952) J Pharmacol Exp Ther. , vol.106 , pp. 364-369
    • Butler, T.C.1    Mahaffee, D.2    Mahaffee, C.3
  • 56
    • 4143079138 scopus 로고    scopus 로고
    • Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of Rand S-mephobarbital in humans
    • Kobayashi K, Morita J, Chiba K, et al. Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of Rand S-mephobarbital in humans. Pharmacogenetics. 2004;14(8):549-556.
    • (2004) Pharmacogenetics. , vol.14 , Issue.8 , pp. 549-556
    • Kobayashi, K.1    Morita, J.2    Chiba, K.3
  • 57
    • 0019471999 scopus 로고
    • Pharmacokinetics and bioavailability of methylphenobarbital in man
    • Hooper WD, Kunze HE, Eadie MJ. Pharmacokinetics and bioavailability of methylphenobarbital in man. Ther Drug Monit. 1981;3:39-44.
    • (1981) Ther Drug Monit. , vol.3 , pp. 39-44
    • Hooper, W.D.1    Kunze, H.E.2    Eadie, M.J.3
  • 58
    • 84984425031 scopus 로고
    • Die Bekanfung epileptischer Anfalle und iher Folgeer Scheinungen mit Prominal
    • Blum E. Die Bekanfung epileptischer Anfalle und iher Folgeer Scheinungen mit Prominal. Dtsch Med Wochenschr. 1932;58:230-236.
    • (1932) Dtsch Med Wochenschr. , vol.58 , pp. 230-236
    • Blum, E.1
  • 59
    • 84883900123 scopus 로고
    • Other barbiturates: methyl-phenobarbital and metharbital
    • Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
    • Eadie MJ. Other barbiturates: methyl-phenobarbital and metharbital. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:357-378.
    • (1989) Antiepileptic Drugs. , pp. 357-378
    • Eadie, M.J.1
  • 60
    • 0018620260 scopus 로고
    • Mephobarbital and phenobarbital plasma concentrations in epileptic patients treated with mephobarbital
    • Kupferberg HJ, Longacre-Shaw J. Mephobarbital and phenobarbital plasma concentrations in epileptic patients treated with mephobarbital. Ther Drug Monit. 1979;1:117-122.
    • (1979) Ther Drug Monit. , vol.1 , pp. 117-122
    • Kupferberg, H.J.1    Longacre-Shaw, J.2
  • 61
    • 0014338849 scopus 로고
    • Perceptual-motor behavior in relation to blood phenobarbital level: a preliminary report
    • Hutt SJ, Jackson PM, Belsham A, et al. Perceptual-motor behavior in relation to blood phenobarbital level: a preliminary report. Dev Med Child Neurol. 1968;10:626-632.
    • (1968) Dev Med Child Neurol. , vol.10 , pp. 626-632
    • Hutt, S.J.1    Jackson, P.M.2    Belsham, A.3
  • 62
    • 84973434623 scopus 로고
    • Presented at the NIH Consensus Development Conference on Febrile Seizures; May 19-21, Bethesda, MD
    • Camfield C. Clinical Trials of Phenobarbital. Presented at the NIH Consensus Development Conference on Febrile Seizures; May 19-21, 1980; Bethesda, MD.
    • (1980) Clinical Trials of Phenobarbital
    • Camfield, C.1
  • 63
    • 0018263659 scopus 로고
    • Memory impairment in epileptic patients: selective effects of phenobarbital concentrations
    • McLeod CM, Dekaban AS, Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentrations. Science. 1978; 202:1102-1104.
    • (1978) Science. , vol.202 , pp. 1102-1104
    • McLeod, C.M.1    Dekaban, A.S.2    Hunt, E.3
  • 64
    • 0030980598 scopus 로고    scopus 로고
    • Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study
    • Willis J, Nelson A, Black FW, et al. Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study. J Child Neurol. 1997;12:169-171.
    • (1997) J Child Neurol. , vol.12 , pp. 169-171
    • Willis, J.1    Nelson, A.2    Black, F.W.3
  • 65
    • 77049143061 scopus 로고
    • Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics
    • Bergstrom WH, Carzoli RF, Lombroso C, et al. Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics. Am J Dis Child. 1952;84:771-772.
    • (1952) Am J Dis Child. , vol.84 , pp. 771-772
    • Bergstrom, W.H.1    Carzoli, R.F.2    Lombroso, C.3
  • 66
    • 84965257938 scopus 로고
    • Acetazolamide in treatment of epilepsy
    • Ansell B, Clarke E. Acetazolamide in treatment of epilepsy. Br Med J. 1956;1:650-661.
    • (1956) Br Med J. , vol.1 , pp. 650-661
    • Ansell, B.1    Clarke, E.2
  • 67
    • 0019851991 scopus 로고
    • Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children
    • Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol. 1981;23:761-769.
    • (1981) Dev Med Child Neurol. , vol.23 , pp. 761-769
    • Forsythe, W.I.1    Owens, J.R.2    Toothill, C.3
  • 68
    • 3042981553 scopus 로고
    • Control of petit mal by acetazolamide
    • Golla FL, Sessions HR. Control of petit mal by acetazolamide. J Ment Sci. 1957;103:214-217.
    • (1957) J Ment Sci. , vol.103 , pp. 214-217
    • Golla, F.L.1    Sessions, H.R.2
  • 69
    • 0000777467 scopus 로고
    • Further evaluation of acetazolamide (Diamox) in treatment of epilepsy
    • Lombroso CT, Davidson DT Jr, Gross-Bianchi ML. Further evaluation of acetazolamide (Diamox) in treatment of epilepsy. J Am Med Assoc. 1956;160:268-272.
    • (1956) J Am Med Assoc. , vol.160 , pp. 268-272
    • Lombroso, C.T.1    Davidson, Jr.D.T.2    Gross-Bianchi, M.L.3
  • 70
    • 0000610426 scopus 로고
    • Anticonvulsant action of Diamox in children
    • Millichap JG. Anticonvulsant action of Diamox in children. Neurology. 1956;6:552-559.
    • (1956) Neurology. , vol.6 , pp. 552-559
    • Millichap, J.G.1
  • 71
    • 0013061288 scopus 로고
    • Carbonic anhydrase inhibition, I: the pharmacology of Diamox (2-acetylamino-1,3,4-thiadiazole-5sulfonamide)
    • Maren TH, Mayer E, Wadsworth BC. Carbonic anhydrase inhibition, I: the pharmacology of Diamox (2-acetylamino-1,3,4-thiadiazole-5sulfonamide). Bull Johns Hopkins Hosp. 1954;95:199-243.
    • (1954) Bull Johns Hopkins Hosp. , vol.95 , pp. 199-243
    • Maren, T.H.1    Mayer, E.2    Wadsworth, B.C.3
  • 72
    • 0001348448 scopus 로고
    • Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor
    • Millichap JG, Woodbury DM, Goodman LS. Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor. J Pharmacol Exp Ther. 1955;115:251-258.
    • (1955) J Pharmacol Exp Ther. , vol.115 , pp. 251-258
    • Millichap, J.G.1    Woodbury, D.M.2    Goodman, L.S.3
  • 73
    • 0027511247 scopus 로고
    • Reduced susceptibility to seizures in carbonic anhydrase II deficient mutant mice
    • Velisek L, Moshé SL, Xu SG, et al. Reduced susceptibility to seizures in carbonic anhydrase II deficient mutant mice. Epilepsy Res. 1993;14:115-121.
    • (1993) Epilepsy Res. , vol.14 , pp. 115-121
    • Velisek, L.1    Moshé, S.L.2    Xu, S.G.3
  • 74
    • 0037122779 scopus 로고    scopus 로고
    • Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties
    • Masereel B, Rolin S, Abbate F, et al. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem. 2002;45:312-320.
    • (2002) J Med Chem. , vol.45 , pp. 312-320
    • Masereel, B.1    Rolin, S.2    Abbate, F.3
  • 75
    • 84910591102 scopus 로고
    • Pharmacology and mechanisms of action of antiepileptic drugs
    • Goldensohn ES, Appel SH, eds.Philadelphia, PA: Lea & Febiger
    • Woodbury DM. Pharmacology and mechanisms of action of antiepileptic drugs. In: Goldensohn ES, Appel SH, eds. Scientific Approaches to Clinical Neurology. Philadelphia, PA: Lea & Febiger; 1977:693-726.
    • (1977) Scientific Approaches to Clinical Neurology. , pp. 693-726
    • Woodbury, D.M.1
  • 76
    • 0036091187 scopus 로고    scopus 로고
    • Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons
    • Leniger T, Wiemann M, Bingmann D, et al. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia. 2002;43:469-474.
    • (2002) Epilepsia. , vol.43 , pp. 469-474
    • Leniger, T.1    Wiemann, M.2    Bingmann, D.3
  • 77
    • 10844237676 scopus 로고
    • Basic mechanisms of seizures: neurophysiological and biochemical etiology
    • Shagass C, Gerson S, Friedhoff AJ, eds.New York: Raven Press
    • Woodbury DM, Kemp JW. Basic mechanisms of seizures: neurophysiological and biochemical etiology. In: Shagass C, Gerson S, Friedhoff AJ, eds. Psychopathology and Brain Dysfunction. New York: Raven Press; 1977:149-182.
    • (1977) Psychopathology and Brain Dysfunction. , pp. 149-182
    • Woodbury, D.M.1    Kemp, J.W.2
  • 78
    • 0009111688 scopus 로고
    • Antiepileptic drugs: carbonic anhydrase inhibitors
    • Glaser GH, Penry JK, Woodbury DM, eds.New York: Raven Press
    • Woodbury DM. Antiepileptic drugs: carbonic anhydrase inhibitors. In: Glaser GH, Penry JK, Woodbury DM, eds. Antiepileptic Drugs: Mechanisms of Action. New York: Raven Press; 1980:617-634.
    • (1980) Antiepileptic Drugs: Mechanisms of Action. , pp. 617-634
    • Woodbury, D.M.1
  • 79
    • 0034992257 scopus 로고    scopus 로고
    • Treatment of typical absence seizures and related epileptic syndromes
    • Panayiotopoulos CP. Treatment of typical absence seizures and related epileptic syndromes. Paediatr Drugs. 2001;3:379-403.
    • (2001) Paediatr Drugs. , vol.3 , pp. 379-403
    • Panayiotopoulos, C.P.1
  • 80
    • 0034961068 scopus 로고    scopus 로고
    • Acetazolamide in women with catamenial epilepsy
    • Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia. 2001;42:746-749.
    • (2001) Epilepsia. , vol.42 , pp. 746-749
    • Lim, L.L.1    Foldvary, N.2    Mascha, E.3    Lee, J.4
  • 81
    • 0025188657 scopus 로고
    • Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy
    • Resor SR, Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology. 1990;40:1677-1681.
    • (1990) Neurology. , vol.40 , pp. 1677-1681
    • Resor, Jr.S.R.1    Resor, L.D.2
  • 82
    • 0036211076 scopus 로고    scopus 로고
    • Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies
    • Katayama F, Miura H, Takanashi S. Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain Dev. 2002;24:150-154.
    • (2002) Brain Dev. , vol.24 , pp. 150-154
    • Katayama, F.1    Miura, H.2    Takanashi, S.3
  • 83
    • 0029965708 scopus 로고    scopus 로고
    • Acetazolamide in the treatment of epilepsy
    • Reiss WG, Oles KS. Acetazolamide in the treatment of epilepsy. Ann Pharmacother. 1996;30:514-519.
    • (1996) Ann Pharmacother. , vol.30 , pp. 514-519
    • Reiss, W.G.1    Oles, K.S.2
  • 84
    • 0006898943 scopus 로고
    • Other antiepileptic drugs: sulfonamides and derivatives
    • Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
    • Woodbury DM, Kemp JW. Other antiepileptic drugs: sulfonamides and derivatives. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:855-876.
    • (1989) Antiepileptic Drugs. , pp. 855-876
    • Woodbury, D.M.1    Kemp, J.W.2
  • 85
    • 0033002623 scopus 로고    scopus 로고
    • Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study
    • Kubota F, Kifune A, Shibata N, et al. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res. 1999;33:93-97.
    • (1999) Epilepsy Res. , vol.33 , pp. 93-97
    • Kubota, F.1    Kifune, A.2    Shibata, N.3
  • 86
    • 0030298437 scopus 로고    scopus 로고
    • Growth suppression in children receiving acetazolamide with antiepileptic drugs
    • Futagi Y, Atani K, Abe J. Growth suppression in children receiving acetazolamide with antiepileptic drugs. Pediatr Neurol. 1996;15:323-326.
    • (1996) Pediatr Neurol. , vol.15 , pp. 323-326
    • Futagi, Y.1    Atani, K.2    Abe, J.3
  • 87
    • 0001890299 scopus 로고
    • Intake of vitamin B-6 and infantile convulsions: a first approximation of requirements of pyridoxine in infants
    • Bessey OA, Adam DJD, Hansen AE. Intake of vitamin B-6 and infantile convulsions: a first approximation of requirements of pyridoxine in infants. Pediatrics. 1957;10:33-44.
    • (1957) Pediatrics. , vol.10 , pp. 33-44
    • Bessey, O.A.1    Adam, D.J.D.2    Hansen, A.E.3
  • 88
    • 0002935936 scopus 로고
    • Ineffectiveness of pyridoxine (vitamin B-6) in the treatment of epilepsy
    • Livingston SJ, Hsu M, Petersen DC. Ineffectiveness of pyridoxine (vitamin B-6) in the treatment of epilepsy. Pediatrics. 1955;16:250-251.
    • (1955) Pediatrics. , vol.16 , pp. 250-251
    • Livingston, S.J.1    Hsu, M.2    Petersen, D.C.3
  • 89
    • 0001851634 scopus 로고
    • Vitamin B-6-dependency infantile convulsions
    • Scriver CR. Vitamin B-6-dependency infantile convulsions. Pediatrics. 1960;26:62-74.
    • (1960) Pediatrics. , vol.26 , pp. 62-74
    • Scriver, C.R.1
  • 90
    • 0342315296 scopus 로고
    • The vitamin B-6 deficiency syndrome in human infancy: biochemical and clinical observations
    • Scriver CR, Hutchison JH. The vitamin B-6 deficiency syndrome in human infancy: biochemical and clinical observations. Pediatrics. 1963;31:240-250.
    • (1963) Pediatrics. , vol.31 , pp. 240-250
    • Scriver, C.R.1    Hutchison, J.H.2
  • 91
    • 0000743130 scopus 로고
    • Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine
    • Hunt AD, Stokes J, McCrory WW, et al. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954;13:140-145.
    • (1954) Pediatrics. , vol.13 , pp. 140-145
    • Hunt, A.D.1    Stokes, J.2    McCrory, W.W.3
  • 92
    • 0014696022 scopus 로고
    • Glutamic acid decarboxylase (GAD) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin B-6 dependency with seizures
    • Scriver CR, Whelan DT. Glutamic acid decarboxylase (GAD) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin B-6 dependency with seizures. Ann N Y Acad Sci. 1969;166:83-96.
    • (1969) Ann N Y Acad Sci. , vol.166 , pp. 83-96
    • Scriver, C.R.1    Whelan, D.T.2
  • 93
    • 0020998093 scopus 로고
    • Late-onset pyridoxine-dependency convulsions
    • Bachmann DS. Late-onset pyridoxine-dependency convulsions. Ann Neurol. 1983;14:692-693.
    • (1983) Ann Neurol. , vol.14 , pp. 692-693
    • Bachmann, D.S.1
  • 94
    • 0026905512 scopus 로고
    • Postneonatal vitamin B-6-dependent epilepsy
    • Coker SB. Postneonatal vitamin B-6-dependent epilepsy. Pediatrics. 1992;90:221-223.
    • (1992) Pediatrics. , vol.90 , pp. 221-223
    • Coker, S.B.1
  • 95
    • 0023584390 scopus 로고
    • Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B-6
    • Kurleman G, Loscher W, Dominick HC, et al. Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B-6. Epilepsy Res. 1987;1:152-154.
    • (1987) Epilepsy Res. , vol.1 , pp. 152-154
    • Kurleman, G.1    Loscher, W.2    Dominick, H.C.3
  • 96
    • 0015081685 scopus 로고
    • Vitamin B 6-dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B 6 dependent convulsion
    • Yoshida T, Tada K, Arakawa T. Vitamin B 6-dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin B 6 dependent convulsion. Tohoku J Exp Med. 1971;104:195-198.
    • (1971) Tohoku J Exp Med. , vol.104 , pp. 195-198
    • Yoshida, T.1    Tada, K.2    Arakawa, T.3
  • 97
    • 1242341236 scopus 로고    scopus 로고
    • Pyridoxine-dependent seizures: a clinical and biochemical conundrum
    • Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta. 2003;1647:36-41.
    • (2003) Biochim Biophys Acta. , vol.1647 , pp. 36-41
    • Baxter, P.1
  • 98
    • 0036214478 scopus 로고    scopus 로고
    • Pyridoxine-dependent seizures: findings from recent studies pose new questions
    • Gospe SM. Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr Neurol. 2002;26:181-185.
    • (2002) Pediatr Neurol. , vol.26 , pp. 181-185
    • Gospe, S.M.1
  • 99
    • 0020546448 scopus 로고
    • Pyridoxine dependent seizures: a wider clinical spectrum
    • Bankier A, Turner M, Hopkins IJ. Pyridoxine dependent seizures: a wider clinical spectrum. Arch Dis Child. 1983;58:415-418.
    • (1983) Arch Dis Child. , vol.58 , pp. 415-418
    • Bankier, A.1    Turner, M.2    Hopkins, I.J.3
  • 100
    • 0021962790 scopus 로고
    • Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants
    • Goutieres F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985;17:117-120.
    • (1985) Ann Neurol. , vol.17 , pp. 117-120
    • Goutieres, F.1    Aicardi, J.2
  • 102
    • 0025730349 scopus 로고
    • Pyridoxine-dependent seizures, clinical therapeutic aspects
    • Haenggeli CA, Girardin E, Paunier L. Pyridoxine-dependent seizures, clinical therapeutic aspects. Eur J Pediatr. 1991;150:452-455.
    • (1991) Eur J Pediatr. , vol.150 , pp. 452-455
    • Haenggeli, C.A.1    Girardin, E.2    Paunier, L.3
  • 103
    • 0345404150 scopus 로고    scopus 로고
    • Longitudinal MRI findings in pyridoxinedependent seizures
    • Gospe SM, Jr, Hecht ST. Longitudinal MRI findings in pyridoxinedependent seizures. Neurology. 1998;51:74-78.
    • (1998) Neurology. , vol.51 , pp. 74-78
    • Gospe, Jr.S.M.1    Hecht, S.T.2
  • 104
    • 0018600474 scopus 로고
    • Pyridoxine-dependent seizures requiring high doses of pyridoxine for control
    • Clarke TA, Saunders BS, Feldman B. Pyridoxine-dependent seizures requiring high doses of pyridoxine for control. Am J Dis Child. 1979;133: 963-965.
    • (1979) Am J Dis Child. , vol.133 , pp. 963-965
    • Clarke, T.A.1    Saunders, B.S.2    Feldman, B.3
  • 105
    • 0020683566 scopus 로고
    • Pyridoxine-dependency seizure: report of a rare presentation
    • Krishnamoorthy KS. Pyridoxine-dependency seizure: report of a rare presentation. Ann Neurol. 1983;13:103-104.
    • (1983) Ann Neurol. , vol.13 , pp. 103-104
    • Krishnamoorthy, K.S.1
  • 106
    • 0029814382 scopus 로고    scopus 로고
    • Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion
    • Bass NE, Wyllie E, Cohen B, et al. Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol. 1996;11:422-424.
    • (1996) J Child Neurol. , vol.11 , pp. 422-424
    • Bass, N.E.1    Wyllie, E.2    Cohen, B.3
  • 107
    • 0017903491 scopus 로고
    • Vitamin B 6-dependent seizures: pathology chemical findings in brain
    • Lott IT, Coulombe T, DiPaolo RV, et al. Vitamin B 6-dependent seizures: pathology chemical findings in brain. Neurology. 1978;28:47-54.
    • (1978) Neurology. , vol.28 , pp. 47-54
    • Lott, I.T.1    Coulombe, T.2    DiPaolo, R.V.3
  • 108
    • 0028022624 scopus 로고
    • Glutamate in pyridoxinedependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine
    • Friedrich AM, Baumeister MD, Gsell W, et al. Glutamate in pyridoxinedependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics. 1994; 94:318-321.
    • (1994) Pediatrics. , vol.94 , pp. 318-321
    • Friedrich, A.M.1    Baumeister, M.D.2    Gsell, W.3
  • 109
    • 0021369529 scopus 로고
    • Cerebrospinal fluid GABA levels in children with infantile spasms
    • Ito M, Mikawa M, Tangiguchi T. Cerebrospinal fluid GABA levels in children with infantile spasms. Neurology. 1984;34:235-238.
    • (1984) Neurology. , vol.34 , pp. 235-238
    • Ito, M.1    Mikawa, M.2    Tangiguchi, T.3
  • 110
    • 0021879046 scopus 로고
    • Cerebrospinal fluid: aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment
    • Loscher W, Siemes H. Cerebrospinal fluid: aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia. 1985;16:314-319.
    • (1985) Epilepsia. , vol.16 , pp. 314-319
    • Loscher, W.1    Siemes, H.2
  • 111
    • 0022559678 scopus 로고
    • High dose B-6 treatment in infantile spasms
    • Blennow G, Starck L. High dose B-6 treatment in infantile spasms. Neuropediatrics. 1986;17:7-10.
    • (1986) Neuropediatrics. , vol.17 , pp. 7-10
    • Blennow, G.1    Starck, L.2
  • 112
    • 0025921989 scopus 로고
    • Vitamin B-6 and valproic acid in treatment of infantile spasms
    • Ito M, Okuno T, Hattori H, et al. Vitamin B-6 and valproic acid in treatment of infantile spasms. Pediatr Neurol. 1991;7:91-96.
    • (1991) Pediatr Neurol. , vol.7 , pp. 91-96
    • Ito, M.1    Okuno, T.2    Hattori, H.3
  • 113
    • 0003004212 scopus 로고
    • Pyridoxal phosphate in the treatment of the West syndrome
    • Akimoto H, Seino M, Ward AA, Jr, eds.New York: Raven Press
    • Ohtsuka Y, Matsuda M, Kohno C, et al. Pyridoxal phosphate in the treatment of the West syndrome. In: Akimoto H, Seino M, Ward AA, Jr, eds. Advances in Epileptology. XIIIth Epilepsy International Symposium. New York: Raven Press; 1982:311-313.
    • (1982) Advances in Epileptology. XIIIth Epilepsy International Symposium. , pp. 311-313
    • Ohtsuka, Y.1    Matsuda, M.2    Kohno, C.3
  • 114
    • 0027326674 scopus 로고
    • Treatment of infantile spasms with high-dosage vitamin B6
    • Pietz J, Benninger C, Schafer H, et al. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia. 1993;34:757-763.
    • (1993) Epilepsia. , vol.34 , pp. 757-763
    • Pietz, J.1    Benninger, C.2    Schafer, H.3
  • 115
    • 18744428938 scopus 로고    scopus 로고
    • Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children
    • Jiao FY, Takuma Y, Wu S, et al. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatr Neurol. 1997;17:54-57.
    • (1997) Pediatr Neurol. , vol.17 , pp. 54-57
    • Jiao, F.Y.1    Takuma, Y.2    Wu, S.3
  • 116
    • 36549011402 scopus 로고    scopus 로고
    • Vitamin B6 related epilepsy during childhood
    • Wang HS, Kuo MF. Vitamin B6 related epilepsy during childhood. Chang Gung Med J. 2007;30(5):396-401.
    • (2007) Chang Gung Med J. , vol.30 , Issue.5 , pp. 396-401
    • Wang, H.S.1    Kuo, M.F.2
  • 117
    • 1242280684 scopus 로고
    • Pyridoxine-dependent convulsions in an infant
    • Garty R, Yonis Z, Braham J, et al. Pyridoxine-dependent convulsions in an infant. Arch Dis Child. 1962;37:21-24.
    • (1962) Arch Dis Child. , vol.37 , pp. 21-24
    • Garty, R.1    Yonis, Z.2    Braham, J.3
  • 118
    • 0022007415 scopus 로고
    • Pyridoxine for neonatal seizures: an unexpected danger
    • Kroll J. Pyridoxine for neonatal seizures: an unexpected danger. Dev Med Child Neurol. 1985;27:369-382.
    • (1985) Dev Med Child Neurol. , vol.27 , pp. 369-382
    • Kroll, J.1
  • 119
    • 0018134207 scopus 로고
    • Pyridoxol metabolism in vitamin B-6 responsive convulsions of early infancy
    • Heeley A, Puch RJP, Clayton BE, et al. Pyridoxol metabolism in vitamin B-6 responsive convulsions of early infancy. Arch Dis Child. 1978;53: 794-802.
    • (1978) Arch Dis Child. , vol.53 , pp. 794-802
    • Heeley, A.1    Puch, R.J.P.2    Clayton, B.E.3
  • 120
    • 0000874589 scopus 로고
    • Experimental study of the effects produced by large doses of vitamin B-6
    • Antopol W, Tarlov IM. Experimental study of the effects produced by large doses of vitamin B-6. J Neuropathol Exp Neurol. 1942;1:330-336.
    • (1942) J Neuropathol Exp Neurol. , vol.1 , pp. 330-336
    • Antopol, W.1    Tarlov, I.M.2
  • 121
    • 0023230365 scopus 로고
    • Characteristics of pyridoxine overdose neuropathy syndrome
    • Dalton K, Dalton JT. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76:8-11.
    • (1987) Acta Neurol Scand. , vol.76 , pp. 8-11
    • Dalton, K.1    Dalton, J.T.2
  • 122
    • 0021930611 scopus 로고
    • Sensory neuropathy with low-dose pyridoxine
    • Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985;35:1466-1468.
    • (1985) Neurology. , vol.35 , pp. 1466-1468
    • Parry, G.J.1    Bredesen, D.E.2
  • 123
    • 0020592458 scopus 로고
    • Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome
    • Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983; 309:445-448.
    • (1983) N Engl J Med. , vol.309 , pp. 445-448
    • Schaumburg, H.1    Kaplan, J.2    Windebank, A.3
  • 124
    • 0024420433 scopus 로고
    • Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication
    • Xu Y, Sladky JT, Brown MJ. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology. 1989;39:1077-1083.
    • (1989) Neurology. , vol.39 , pp. 1077-1083
    • Xu, Y.1    Sladky, J.T.2    Brown, M.J.3
  • 125
    • 0026639426 scopus 로고
    • Dose response, coasting, and differential fibre vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity
    • Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fibre vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42: 1367-1370.
    • (1992) Neurology. , vol.42 , pp. 1367-1370
    • Berger, A.R.1    Schaumburg, H.H.2    Schroeder, C.3
  • 126
    • 0021148334 scopus 로고
    • More on neuropathy from pyridoxine abuse
    • Berger A, Schaumburg HH. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984;311:986-987.
    • (1984) N Engl J Med. , vol.311 , pp. 986-987
    • Berger, A.1    Schaumburg, H.H.2
  • 127
    • 0023617573 scopus 로고
    • Acute sensory neuropathy-neuronopathy from pyridoxine overdose
    • Albin R, Alpers JW, Greenberg HS, et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology. 1987;37:1729-1732.
    • (1987) Neurology. , vol.37 , pp. 1729-1732
    • Albin, R.1    Alpers, J.W.2    Greenberg, H.S.3
  • 128
  • 130
    • 0021490934 scopus 로고
    • Pyridoxine dependent seizures
    • Reynolds RD. Pyridoxine dependent seizures. Arch Dis Child. 1984;59: 906-907.
    • (1984) Arch Dis Child. , vol.59 , pp. 906-907
    • Reynolds, R.D.1
  • 131
    • 0025899377 scopus 로고
    • No sensory neuropathy during pyridoxine treatment in homocystinuria
    • Mpofu C, Alani SM, Whitehouse C, et al. No sensory neuropathy during pyridoxine treatment in homocystinuria. Arch Dis Child. 1991;66: 1081-1082.
    • (1991) Arch Dis Child. , vol.66 , pp. 1081-1082
    • Mpofu, C.1    Alani, S.M.2    Whitehouse, C.3
  • 132
    • 0028897913 scopus 로고
    • Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy
    • McLachlan RS, Brown WF. Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Can J Neurol Sci. 1995;22:50-51.
    • (1995) Can J Neurol Sci. , vol.22 , pp. 50-51
    • McLachlan, R.S.1    Brown, W.F.2
  • 133
    • 0000473045 scopus 로고
    • Analysis of 52 cases of epilepsy observed by author
    • Locock C. In discussion of Sieveking EH. Analysis of 52 cases of epilepsy observed by author. Lancet. 1857;1:527.
    • (1857) Lancet. , vol.1 , pp. 527
    • Locock, C.1
  • 134
    • 0018577690 scopus 로고
    • Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100, bromide and muscimol
    • Palachios JM, Nieholt DL, Kuhar MJ. Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100, bromide and muscimol. Brain Res. 1979;179:390-395.
    • (1979) Brain Res. , vol.179 , pp. 390-395
    • Palachios, J.M.1    Nieholt, D.L.2    Kuhar, M.J.3
  • 135
    • 0002521928 scopus 로고
    • Bromides
    • Woodbury DM, Penry JK, Pippenger CE, eds.2nd ed. New York: Raven Press
    • Woodbury DM, Pippenger CE. Bromides. In: Woodbury DM, Penry JK, Pippenger CE, eds. Antiepileptic Drugs. 2nd ed. New York: Raven Press; 1986:791-801.
    • (1986) Antiepileptic Drugs. , pp. 791-801
    • Woodbury, D.M.1    Pippenger, C.E.2
  • 136
    • 0022851347 scopus 로고
    • Pharmacokinetics of oral and intravenous bromide in normal volunteers
    • Vaiseman N, Koren G, Pencharz P. Pharmacokinetics of oral and intravenous bromide in normal volunteers. Clin Toxicol. 1986;24:403-413.
    • (1986) Clin Toxicol. , vol.24 , pp. 403-413
    • Vaiseman, N.1    Koren, G.2    Pencharz, P.3
  • 137
    • 0008917280 scopus 로고
    • Bromides
    • Levy R, Mattson R, Meldrum B, et al., eds.3rd ed. New York: Raven Press
    • Dreifuss FE. Bromides. In: Levy R, Mattson R, Meldrum B, et al., eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press; 1989:877-879.
    • (1989) Antiepileptic Drugs. , pp. 877-879
    • Dreifuss, F.E.1
  • 138
    • 0024213254 scopus 로고
    • Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood
    • Ernst J, Doose H, Baier WK. Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev. 1988;10:385-388.
    • (1988) Brain Dev. , vol.10 , pp. 385-388
    • Ernst, J.1    Doose, H.2    Baier, W.K.3
  • 139
    • 0028075820 scopus 로고
    • Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant
    • Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia. 1994;35:1140-1145.
    • (1994) Epilepsia. , vol.35 , pp. 1140-1145
    • Oguni, H.1    Hayashi, K.2    Oguni, M.3
  • 140
    • 0026734979 scopus 로고
    • Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: a clinical study
    • Steinhoff BJ, Kruse R. Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: a clinical study. Brain Dev. 1992;14:144-149.
    • (1992) Brain Dev. , vol.14 , pp. 144-149
    • Steinhoff, B.J.1    Kruse, R.2
  • 141
    • 0035408386 scopus 로고    scopus 로고
    • Anticonvulsant medications
    • Stewart LS. Anticonvulsant medications. Emerg Med Serv. 2001;30:56-66.
    • (2001) Emerg Med Serv. , vol.30 , pp. 56-66
    • Stewart, L.S.1
  • 142
    • 0030875849 scopus 로고    scopus 로고
    • Bromism: intoxication from a rare anticonvulsant therapy
    • James LP, Farrar HC, Griebel ML, et al. Bromism: intoxication from a rare anticonvulsant therapy. Pediatr Emerg Care. 1997;13:268-270.
    • (1997) Pediatr Emerg Care. , vol.13 , pp. 268-270
    • James, L.P.1    Farrar, H.C.2    Griebel, M.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.